Combating Childhood Obesity Through Nurse Practitioner-Led School Wellness Program

Overweight children and childhood obesity have been identified as an area of national and global concern. The prevalence of childhood obesity has been described as one of the most common chronic childhood conditions (Faguy, 2016). During the past decade, childhood obesity has been on the rise throughout the nation with an estimated childhood rate of 42 million to 70 million by 2025 (World Health Organization [WHO], 2014). The purpose of this prospective, quantitative study was to develop and implement a family nurse practitioner-led wellness intervention program in the school setting that incorporated nutrition and physical activity for adolescents. The review of literature revealed a lack of evidence regarding effectiveness of FNP-led wellness initiative in the school setting. Specific aims were to evaluate the pre- and post-intervention activity level and self-efficacy for diet and exercise of adolescents ages 14 to 17 during a 4-week FNP led school-based initiatives. Activity level was assessed through the use of Jawbone UP Move and Patient-Centered Assessment & Counseling for Exercise (PACE+) surveys. Participants experienced a significant improvement in their perspectives related to limiting the consumption of dietary when comparing baseline data to 4 weeks. Participants showed an increase in physical activity through the Jawbone UP Move from baseline to the end of the program. Participants demonstrated a reduction in diastolic blood pressure from baseline to completion of study. This translational childhood obesity school based project will contribute to the body of knowledge regarding FNPs and their role in reducing the prevalence and incidence of childhood obesity

Border Insecurity: Reading Transnational Environments in Jim Lynch’s Border Songs

This article applies an eco-critical approach to contemporary American fiction about the Canada-US border, examining Jim Lynch’s portrayal of the British Columbia-Washington borderlands in his 2009 novel Border Songs. It argues that studying transnational environmental actors in border texts—in this case, marijuana, human migrants, and migratory birds—helps illuminate the contingency of political boundaries, problems of scale, and discourses of risk and security in cross-border regions after 9/11. Further, it suggests that widening the analysis of trans-border activity to include environmental phenomena productively troubles concepts of nature and regional belonging in an era of climate change and economic globalization. Cet article propose une lecture écocritique de la fiction étatsunienne contemporaine portant sur la frontière entre le Canada et les États-Unis, en étudiant le portrait donné par Jim Lynch de la région frontalière entre la Colombie-Britannique et Washington dans son roman Border Songs, paru en 2009. L’article soutient que l’étude, dans les textes sur la frontière, des acteurs environnementaux transnationaux – dans ce cas-ci, la marijuana, les migrants humains et les oiseaux migratoires – jette un jour nouveau sur la contingence des limites territoriales politiques, des problèmes d’échelle et des discours sur le risque et la sécurité des régions transfrontalières après les évènements du 11 septembre 2001. Il suggère également qu’en élargissant l’analyse de l’activité transfrontalière pour y inclure les phénomènes environnementaux, on brouille de façon productive les concepts de nature et d’appartenance régionale d’une époque marquée par les changements climatiques et la mondialisation de l’économie

Geological history of the Winchcombe meteorite - A new cm Chrondrite fall

Introduction: The Mighei-like (CM) carbonaceous chondrites are the largest class of hydrated meteorites, representing collisionally derived fragments of water-rich asteroids [1,2]. Most (>95%) are breccias, whose clasts sample a range of aqueous alteration extents [3]. They can therefore act as “snapshots” recording the progression of fluidrock interaction on the CM parent body. Conversely, analysis of the material between clasts (termed cataclastic matrix) provides an opportunity to study the post-hydration history of the CM parent body, specifically its fragmentation and re-accretion. Here, we investigate both aspects of the CM chondrites’ geological history through study of the newly recovered fall: Winchcombe [4, 5]. Methods: Sixteen polished sections with a total area of 190 mm2 were generated for this work. They were studied under scanning electron microscopy (SEM) using backscattered electron (BSE) imaging, energy dispersive X-ray spectroscopy (EDX) and electron microprobe analysis (EMPA). These sections sample the two largest masses (the main mass [320 g] and the agricultural field stone [152 g]) recovered from the Winchcombe strewn field [4]. Results: Winchcombe is a breccia, composed of lithological clasts held within a cataclastic matrix. We identified eight distinct lithologies. Their aqueous alteration extents vary between intensely altered CM2.0 and moderately altered CM2.6 [6]. Although no lithology dominates, three rock types represent >70% of the studied area. Several lithologies contain abundant tochilinite-cronstedtite intergrowths (TCIs). Type-II forms with zoned textures are most common, typically they have Fe-rich rims (“FeO”/SiO2 wt.%: 1-5) and Mg-rich cores (“FeO”/SiO2 wt.%: < 1), however, forms with hollow cores or cores containing a mix of phyllosilicate and calcite or phyllosilciates and anhydrous silicate are also found. The cataclastic matrix represents ~15% of the studied area. It has a coarse, heterogenous texture and includes abundant subangular fragments. Fragments include the full range of CM chondrite components (e.g. Fe-sulphides, whole chondrules with or without fine-grained rims, olivine and pyroxene grains, serpentine, carbonate grains, TCI clusters, as well as coherent blocks of fine-grained matrix). The cataclastic matrix is, therefore, a complex mix of components, with both heavily altered and mildly altered phases found in close association. Another striking feature is the apparent low abundance (< 3 area%) of identifiable whole chondrules. Discussion and conclusions: Our data suggest that both anhydrous silicates and carbonates (T1a calcites) act as precursor phases for type-II TCI formation. Cross-cutting relationships allow the sequence of mineralization to be reconstructed. Initially, inward dissolution by Fe-rich and S-rich fluids forms rims composed of intermixed tochilinite and cronstedtite. In the intermediate stages of type-II TCI formation, further dissolution continues without concurrent precipitation, resulting in the formation of hollow structures. These voids were later infilled, most often by Mg-rich phyllosilicates. As alteration advanced, early-formed secondary phases became unstable and were either dissolved (e.g. T1a calcites) or chemically altered (e.g. TCI rims). The presence of numerous lithological clasts with variable aqueous alteration extents and abrupt boundaries found in close juxtaposition indicates that the cataclastic matrix formed by the deposition of fines, alongside larger fragments (the clasts), on or near the surface of the parent asteroid. Furthermore, the composition of the cataclastic matrix is consistent with formation by fragmentation and mixing of debris derived from the entire clast population. The cataclastic matrix is, therefore, interpreted as an impact-derived fallback breccia. Analysis of grain size and texture suggests that disruption of the original parent asteroid responded by intergranular fracture at grain sizes <100 μm, while larger phases, such as whole chondrules, splintered apart. Re-accretion formed a poorly lithified rubble-pile body. During atmospheric entry, the meteoroid broke apart with new fractures preferentially cutting through the weaker cataclastic matrix and thereby separating the Winchcombe meteoroid into its component- lithological clasts. Thus, the strength of the cataclastic matrix imparts a significant control on the survival of CM chondrite meteoroids. References: [1] McSween, 1979. GCA, 43:1761-1770. [2] Suttle et al. 2021. GCA, 299:219-256. [3] Bischoff, et al. 2017, 80th MetSoc. (Abstr.#6089), [4] Meteoritical Bulletin Database, Winchcombe entry (available at: https://www.lpi.usra.edu/meteor/metbull.php?code=74388). [5] Daly et al., (this meeting). [6] Rubin et al. 2007,GCA, 71:2361-2382

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.

Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined<5 × 10(-8)) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist

Many Labs 5:Testing pre-data collection peer review as an intervention to increase replicability

Replication studies in psychological science sometimes fail to reproduce prior findings. If these studies use methods that are unfaithful to the original study or ineffective in eliciting the phenomenon of interest, then a failure to replicate may be a failure of the protocol rather than a challenge to the original finding. Formal pre-data-collection peer review by experts may address shortcomings and increase replicability rates. We selected 10 replication studies from the Reproducibility Project: Psychology (RP:P; Open Science Collaboration, 2015) for which the original authors had expressed concerns about the replication designs before data collection; only one of these studies had yielded a statistically significant effect (p < .05). Commenters suggested that lack of adherence to expert review and low-powered tests were the reasons that most of these RP:P studies failed to replicate the original effects. We revised the replication protocols and received formal peer review prior to conducting new replication studies. We administered the RP:P and revised protocols in multiple laboratories (median number of laboratories per original study = 6.5, range = 3?9; median total sample = 1,279.5, range = 276?3,512) for high-powered tests of each original finding with both protocols. Overall, following the preregistered analysis plan, we found that the revised protocols produced effect sizes similar to those of the RP:P protocols (?r = .002 or .014, depending on analytic approach). The median effect size for the revised protocols (r = .05) was similar to that of the RP:P protocols (r = .04) and the original RP:P replications (r = .11), and smaller than that of the original studies (r = .37). Analysis of the cumulative evidence across the original studies and the corresponding three replication attempts provided very precise estimates of the 10 tested effects and indicated that their effect sizes (median r = .07, range = .00?.15) were 78% smaller, on average, than the original effect sizes (median r = .37, range = .19?.50)

Genetic mechanisms of critical illness in COVID-19.

Host-mediated lung inflammation is present1, and drives mortality2, in the critical illness caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with critical illness may identify mechanistic targets for therapeutic development3. Here we report the results of the GenOMICC (Genetics Of Mortality In Critical Care) genome-wide association study in 2,244 critically ill patients with COVID-19 from 208 UK intensive care units. We have identified and replicated the following new genome-wide significant associations: on chromosome 12q24.13 (rs10735079, P = 1.65 × 10-8) in a gene cluster that encodes antiviral restriction enzyme activators (OAS1, OAS2 and OAS3); on chromosome 19p13.2 (rs74956615, P = 2.3 × 10-8) near the gene that encodes tyrosine kinase 2 (TYK2); on chromosome 19p13.3 (rs2109069, P = 3.98 ×  10-12) within the gene that encodes dipeptidyl peptidase 9 (DPP9); and on chromosome 21q22.1 (rs2236757, P = 4.99 × 10-8) in the interferon receptor gene IFNAR2. We identified potential targets for repurposing of licensed medications: using Mendelian randomization, we found evidence that low expression of IFNAR2, or high expression of TYK2, are associated with life-threatening disease; and transcriptome-wide association in lung tissue revealed that high expression of the monocyte-macrophage chemotactic receptor CCR2 is associated with severe COVID-19. Our results identify robust genetic signals relating to key host antiviral defence mechanisms and mediators of inflammatory organ damage in COVID-19. Both mechanisms may be amenable to targeted treatment with existing drugs. However, large-scale randomized clinical trials will be essential before any change to clinical practice

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Peri-operative red blood cell transfusion in neonates and infants: NEonate and Children audiT of Anaesthesia pRactice IN Europe: A prospective European multicentre observational study

BACKGROUND: Little is known about current clinical practice concerning peri-operative red blood cell transfusion in neonates and small infants. Guidelines suggest transfusions based on haemoglobin thresholds ranging from 8.5 to 12 g dl-1, distinguishing between children from birth to day 7 (week 1), from day 8 to day 14 (week 2) or from day 15 (≥week 3) onwards. OBJECTIVE: To observe peri-operative red blood cell transfusion practice according to guidelines in relation to patient outcome. DESIGN: A multicentre observational study. SETTING: The NEonate-Children sTudy of Anaesthesia pRactice IN Europe (NECTARINE) trial recruited patients up to 60 weeks' postmenstrual age undergoing anaesthesia for surgical or diagnostic procedures from 165 centres in 31 European countries between March 2016 and January 2017. PATIENTS: The data included 5609 patients undergoing 6542 procedures. Inclusion criteria was a peri-operative red blood cell transfusion. MAIN OUTCOME MEASURES: The primary endpoint was the haemoglobin level triggering a transfusion for neonates in week 1, week 2 and week 3. Secondary endpoints were transfusion volumes, 'delta haemoglobin' (preprocedure - transfusion-triggering) and 30-day and 90-day morbidity and mortality. RESULTS: Peri-operative red blood cell transfusions were recorded during 447 procedures (6.9%). The median haemoglobin levels triggering a transfusion were 9.6 [IQR 8.7 to 10.9] g dl-1 for neonates in week 1, 9.6 [7.7 to 10.4] g dl-1 in week 2 and 8.0 [7.3 to 9.0] g dl-1 in week 3. The median transfusion volume was 17.1 [11.1 to 26.4] ml kg-1 with a median delta haemoglobin of 1.8 [0.0 to 3.6] g dl-1. Thirty-day morbidity was 47.8% with an overall mortality of 11.3%. CONCLUSIONS: Results indicate lower transfusion-triggering haemoglobin thresholds in clinical practice than suggested by current guidelines. The high morbidity and mortality of this NECTARINE sub-cohort calls for investigative action and evidence-based guidelines addressing peri-operative red blood cell transfusions strategies. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02350348

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead